A recent study was published in which the investigators examined the levels of 55 different biomarkers, such as cytokines, chemokines, acute phase proteins, coagulation and fibrinolysis factors, from 187 serum samples from 86 SUDV-infected Ebola hemorrhagic fever patients from the 2000–2001 outbreak in the Gulu district of Uganda (McElroy et al., 2014). The gene discussed is PROS1; the disease is Ebola hemorrhagic fever.